Covered recipient · General Payments record
NATHAN L ROBERTS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$750.02
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.12 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| COLOPLAST CORP | $68.07 | 1 |
| Novo Nordisk AS | $59.11 | 3 |
| Acerta Pharma LLC | $51.74 | 3 |
| Lilly USA, LLC | $37.43 | 2 |
| DEXCOM, INC. | $22.88 | 1 |
| Exact Sciences Corporation | $18.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $18.92 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105520681 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.97 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104348250 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104530806 | CMS |
| COLOPLAST CORP | $68.07 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117438721 | CMS |
| Dexcom, Inc. | $22.88 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153324969 | CMS |
| Exact Sciences Corporation | $18.89 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114856866 | CMS |
| Lilly USA, LLC | $16.02 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135175887 | CMS |
| Lilly USA, LLC | $21.41 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135269739 | CMS |
| Novo Nordisk Inc | $16.93 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097396424 | CMS |
| Novo Nordisk Inc | $18.37 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097384333 | CMS |
| Novo Nordisk Inc | $23.81 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096762077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.